Charles Ryan Yates
12Patents
2h-index
32Co-inventors
50Inventor score
Filing activity: Mar 25, 2004 → Aug 11, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8115031B2 | Anti-inflammatory quinic acid derivatives for oral administration | Chemistry; Metallurgy | 3 | Active |
| US7018816B2 | Real-time polymerase chain reaction-based genotyping assay for single nucleotide polymorphism | Chemistry; Metallurgy | 2 | Expired |
| US10369133B2 | Immunosuppressive compounds and therapeutics | Human Necessities | 0 | Active |
| US9187449B2 | Compounds with increased specificity for the treatment of glioma | Human Necessities | 0 | Active |
| US9567288B2 | Crystalline salts of (Z)-O-octadec-9-en-1-yl O,O-dihydrogen phosphorothioate | Chemistry; Metallurgy | 0 | Active |
| US8906965B2 | Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation | Human Necessities | 0 | Active |
| US9834525B2 | Inhibitors of paxillin function and related compositions and methods | Human Necessities | 0 | Active |
| US11752121B2 | SmartCore compositions and methods | Human Necessities | 0 | Active |
| US9566255B2 | Method for regulating retinal endothelial cell viability | Human Necessities | 0 | Active |
| US8507523B2 | Therapeutic tetrahydroisoquinoline-based compositions for cancer therapy | Chemistry; Metallurgy | 0 | Active |
| US7888365B2 | Tri-aryl/heteroaromatic cannabinoids and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10010516B2 | Method for regulating retinal endothelial cell viability | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.